Leafly Launches New Data-Sharing Program To Advance Cannabis Research

Leafly Holdings, Inc. LFLY launched a new program that allows accredited cannabis researchers to supplement their work with a large cannabis dataset that would otherwise not be available.

Leafly is the informed way to shop for weed and its cannabis data library includes tens of thousands of cannabinoid and terpene strain profiles from the Leafly-Certified Labs Program, subjective strain effects from consumer reviews, and cannabis popularity metrics. This data does not include identifiable customer information and is curated to be of the most use to academic researchers that study the various scientific compounds of cannabis.

“As the cultural and legal landscapes of cannabis access and consumption continue to evolve, the need for more intensive research cannot be understated,” stated Nick Jikomes, PhD and director of science & innovation for Leafly. “After several successful partnerships with university institutions, we decided to open up our data library to the rest of the cannabis academic community. We hope to help play a role in creating universal understanding of this magical and mysterious plant.”

Earlier this year, Leafly and the University of Colorado Boulder co-published research on the chemical composition of marijuana products. The study - the largest analysis of its kind - found that commercial cannabis labels “do not consistently align with the observed chemical diversity” of the product, demonstrating a need for a standardized labeling system across the cannabis industry.

“Leafly was an outstanding research partner in an area that desperately needs less hot air and more empirical research. Leafly provided its one-of-a-kind dataset and made their experts available to answer our questions,” stated Brian Keegan, Ph.D. and assistant professor in the department of information science at the University of Colorado Boulder. “We went from a research question and design to executing agreements, shared data, and submitting a collaborative manuscript in the space of nine months. That is less time than I wait on most grant proposals and journal manuscript decisions.”

Photo by Thiago Patriota on Unsplash

Related News

ScottsMiracle-Gro, TerrAscend, Canopy Growth & Other Large Cannabis Stocks Announce Earnings Release Dates

GOP Video Warns Of Cannabis Being Laced With Fentanyl Despite Studies Saying Otherwise

Cannabis Training: Masters Of Cannabis Certification Program Is Taking Off In Colorado

 

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsBrian KeeganNick JikomesUniversity of Colorado Boulder
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...